{"id":53802,"date":"2023-02-09T18:02:16","date_gmt":"2023-02-09T17:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/"},"modified":"2023-02-09T18:02:16","modified_gmt":"2023-02-09T17:02:16","slug":"iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/","title":{"rendered":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year"},"content":{"rendered":"
\n

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA<\/a>\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to FORTUNE magazine\u2019s \u201cWorld\u2019s Most Admired Companies\u201d list for the sixth consecutive year.\n<\/p>\n

<\/a><\/p>\n

\nOnce again, IQVIA earned the first-place ranking within FORTUNE\u2019s Health Care: Pharmacy and Other Services<\/i> category and ranked number one for innovation, people management, use of corporate assets, social responsibility, quality of products and services, global competitiveness and long-term investment value.\n<\/p>\n

\n\u201cIt is an honor to be named to FORTUNE\u2019s list of the World\u2019s Most Admired Companies for the sixth year in a row. This distinction is a recognition of the impact our 86,000 employees have on driving healthcare forward. Their passion and expertise drive innovations that help improve patient outcomes across the world,\u201d said IQVIA Chairman and CEO Ari Bousbib.\n<\/p>\n

\nFORTUNE\u2019s World’s Most Admired Companies list is the definitive report card on corporate reputation. Since 1997, FORTUNE has identified, selected, and ranked the World\u2019s Most Admired Companies, identifying the business practices that make these companies highly regarded among their peers.\n<\/p>\n

\nMost Admired Company Survey Methodology<\/b>\n<\/p>\n

\nFORTUNE collaborated with Korn Ferry on this survey of corporate reputation. They began with a universe of about 1,500 candidates: the 1,000 largest U.S. companies ranked by revenue, along with non-U.S. companies in the Fortune Global 500 database that have revenues of $10 billion or more. The list was then winnowed to the highest-revenue companies in each industry, a total of 645 in 27 countries, and the top-rated companies were picked from that pool.\n<\/p>\n

\nTo determine the best-regarded companies in 52 industries, Korn Ferry asked executives, directors, and analysts to rate enterprises in their own industry on nine criteria, from investment value and quality of management and products to social responsibility and ability to attract talent. A company\u2019s score must rank in the top half of its industry survey to be listed.\n<\/p>\n

\nAbout IQVIA<\/b>\n<\/p>\n

\nIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence\u2122 delivers powerful insights with speed and agility \u2014 enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.\n<\/p>\n

\nIQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA\u2019s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNick Childs, IQVIA Investor Relations (nick.childs@iqvia.com<\/a>)
\n
+1.973.316.3828\n<\/p>\n

\nTrent Brown, IQVIA Media Relations (trent.brown@iqvia.com<\/a>)
\n
+1.919.780.3221\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to FORTUNE magazine\u2019s \u201cWorld\u2019s Most Admired Companies\u201d list for the sixth consecutive year. Once again, IQVIA earned the first-place ranking within FORTUNE\u2019s Health Care: Pharmacy and Other Services … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53802","6":"format-standard","7":"category-industry"},"yoast_head":"\nIQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to FORTUNE magazine\u2019s \u201cWorld\u2019s Most Admired Companies\u201d list for the sixth consecutive year. Once again, IQVIA earned the first-place ranking within FORTUNE\u2019s Health Care: Pharmacy and Other Services ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-09T17:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year\",\"datePublished\":\"2023-02-09T17:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/\"},\"wordCount\":552,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230209005575\\\/en\\\/1710147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/\",\"name\":\"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230209005575\\\/en\\\/1710147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"datePublished\":\"2023-02-09T17:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230209005575\\\/en\\\/1710147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230209005575\\\/en\\\/1710147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/","og_locale":"en_US","og_type":"article","og_title":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend","og_description":"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to FORTUNE magazine\u2019s \u201cWorld\u2019s Most Admired Companies\u201d list for the sixth consecutive year. Once again, IQVIA earned the first-place ranking within FORTUNE\u2019s Health Care: Pharmacy and Other Services ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-09T17:02:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year","datePublished":"2023-02-09T17:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/"},"wordCount":552,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/","url":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/","name":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","datePublished":"2023-02-09T17:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230209005575\/en\/1710147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iqvia-named-to-fortunes-2023-list-of-worlds-most-admired-companies-ranked-1-in-its-category-for-the-second-consecutive-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"IQVIA Named to FORTUNE\u2019s 2023 List of \u201cWorld\u2019s Most Admired Companies,\u201d Ranked #1 in Its Category for the Second Consecutive Year"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53802"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53802\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}